Overview

Piramal Pharma Limited operates in the pharmaceutical sector with three main divisions: Piramal Pharma Solutions (PPS), Piramal Critical Care (PCC), and the Consumer Products Division (CPD). PPS provides development and manufacturing solutions as a Contract Development and Manufacturing Organization (CDMO), while PCC focuses on hospital generics, especially inhaled anesthetics, serving over 100 countries. The CPD offers well-known self-care brands in India. Piramal Pharma stands out from competitors through its extensive manufacturing capabilities and global distribution network, aiming to meet diverse healthcare needs.

Simplify's Take

What believers are saying

• Increased demand for CDMO services as companies outsource drug development.
• Growing market for inhaled anesthetics due to advancements in surgical procedures.
• Rising consumer interest in self-care products, especially in emerging markets.

What critics are saying

• Increased competition in the CDMO sector from companies like Lonza and Catalent.
• Rising cost of raw materials due to geopolitical tensions and trade restrictions.
• Regulatory scrutiny on inhaled anesthetics in key markets like the USA and Europe.

What makes Piramal Pharma unique

• Piramal Pharma operates through three main divisions: PPS, PCC, and CPD.
• PPS offers comprehensive CDMO services across the drug lifecycle globally.
• PCC specializes in complex hospital generics, particularly inhaled anesthetics.

Help us improve and share your feedback! Did you find this helpful?

YesNo